Description

CO-SENNA TAB offers a reliable solution for those seeking relief from constipation through its dual-action formulation. Each film-coated tablet combines two active ingredients: 50 mg of docusate sodium, a stool softener, and 8 mg of sennosides, a stimulant laxative. This combination is designed to provide gentle, effective relief typically within 6 to 12 hours, making it suitable for overnight use.

How It Works

• Docusate Sodium: Increases the water content in the bowel, softening stools and making them easier to pass.
• Sennosides: Derived from natural senna, these compounds stimulate bowel muscle contractions, promoting bowel movements.

Recommended Use

CO-SENNA TAB is intended for adults and children aged 12 years and over. The recommended dosage is 1 to 2 tablets taken at night, with the option to increase up to 4 tablets if necessary. It is advised to take the tablets with plenty of water for optimal results.

Tablet Characteristics

• Appearance: Round, biconvex, film-coated tablets in a brown or red-brown color.
• Size: Approximately 11/32 inches in diameter.
• Packaging: Available in various pack sizes, including 8, 20, 30, 45, 90, 100, and 200 tablets.

Storage Instructions

• Store below 25–30°C, as specified on the packaging.
• Keep tablets in their original packaging to protect from light.

Precautions and Contraindications

CO-SENNA TAB should not be used by individuals with hypersensitivity to its active ingredients or excipients. It is also contraindicated in cases of abdominal pain, nausea, vomiting, diarrhoea, and certain other gastrointestinal conditions. Prolonged use is not recommended unless under medical supervision, as it may lead to dependence or bowel issues.

Potential Side Effects

Some users may experience abdominal discomfort, cramps, or diarrhoea. A harmless side effect includes urine discoloration to a red-brown hue. Rarely, allergic reactions or electrolyte imbalances may occur.

Additional Features

• Free from sugar, gluten, lactose, and preservatives.
• Not recommended for use during pregnancy or breastfeeding unless advised by a healthcare professional.

Regulatory Information

CO-SENNA TAB is a registered medicine with ARTG ID 474589 and is not scheduled under the Australian medicines and poisons schedule, indicating no special restrictions. It is also listed on the Repatriation Schedule of Pharmaceutical Benefits (RPBS) as of May 1, 2025.

For best results, users are encouraged to maintain adequate fluid intake, dietary fibre, and mobility. Always read the label and use as directed. If symptoms persist, consulting a healthcare professional is advised.